Association between Trimetazidine and Parkinsonism: A Population-Based Study

Conclusions: Treatment with TMZ was a statistically significant predictor of a new diagnosis of parkinsonism. Efforts should focus on close monitoring of, and education on, TMZ use in relation to DIP in all patients who are prescribed TMZ, including those with preexisting extrapyramidal and movement disorders.Neuroepidemiology 2019;52:220 –226
Source: Neuroepidemiology - Category: Epidemiology Source Type: research